Prime Medicine IncNASDAQ:PRME
- LAST PRICE5.6100
- TODAY'S CHANGE (%)-0.0400 (-0.7080%)
- Bid / Lots5.5700/ 10
- Ask / Lots5.8900/ 1
- Open / Previous Close5.7800 / 5.6500
- Day Range
- 52 Week Range
- Volume508,146
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PRME |
|---|---|---|
| 09:32 ET | 15035 | 5.7 |
| 09:34 ET | 273 | 5.715 |
| 09:36 ET | 800 | 5.69 |
| 09:38 ET | 3681 | 5.705 |
| 09:39 ET | 3003 | 5.705 |
| 09:41 ET | 3100 | 5.805 |
| 09:43 ET | 438 | 5.79 |
| 09:45 ET | 700 | 5.82 |
| 09:48 ET | 831 | 5.815 |
| 09:50 ET | 3833 | 5.86 |
| 09:52 ET | 1250 | 5.86 |
| 09:54 ET | 200 | 5.915 |
| 09:56 ET | 6471 | 5.9 |
| 09:57 ET | 975 | 5.88 |
| 09:59 ET | 800 | 5.86 |
| 10:01 ET | 6213 | 5.9 |
| 10:03 ET | 700 | 5.905 |
| 10:06 ET | 2462 | 5.9 |
| 10:08 ET | 400 | 5.86 |
| 10:10 ET | 1900 | 5.82 |
| 10:12 ET | 2819 | 5.84 |
| 10:14 ET | 1958 | 5.7607 |
| 10:15 ET | 5081 | 5.765 |
| 10:17 ET | 1790 | 5.73 |
| 10:19 ET | 744 | 5.71 |
| 10:21 ET | 400 | 5.67 |
| 10:24 ET | 1100 | 5.6606 |
| 10:28 ET | 10080 | 5.6 |
| 10:30 ET | 1600 | 5.58 |
| 10:32 ET | 1093 | 5.54 |
| 10:33 ET | 3804 | 5.54 |
| 10:35 ET | 3575 | 5.6 |
| 10:37 ET | 1786 | 5.6 |
| 10:39 ET | 1716 | 5.63 |
| 10:42 ET | 300 | 5.65 |
| 10:44 ET | 959 | 5.67 |
| 10:46 ET | 1506 | 5.67 |
| 10:48 ET | 200 | 5.66 |
| 10:50 ET | 2320 | 5.62 |
| 10:51 ET | 988 | 5.61 |
| 10:53 ET | 2346 | 5.605 |
| 10:55 ET | 2087 | 5.61 |
| 10:57 ET | 700 | 5.63 |
| 11:02 ET | 882 | 5.67 |
| 11:04 ET | 934 | 5.64 |
| 11:08 ET | 2064 | 5.61 |
| 11:09 ET | 431 | 5.63 |
| 11:13 ET | 100 | 5.63 |
| 11:15 ET | 100 | 5.61 |
| 11:18 ET | 1625 | 5.62 |
| 11:22 ET | 300 | 5.64 |
| 11:24 ET | 100 | 5.65 |
| 11:26 ET | 757 | 5.6599 |
| 11:27 ET | 600 | 5.6589 |
| 11:31 ET | 1099 | 5.6416 |
| 11:36 ET | 400 | 5.65 |
| 11:40 ET | 100 | 5.68 |
| 11:42 ET | 400 | 5.68 |
| 11:45 ET | 1200 | 5.7 |
| 11:47 ET | 1371 | 5.71 |
| 11:49 ET | 600 | 5.7012 |
| 11:51 ET | 100 | 5.704 |
| 11:54 ET | 106 | 5.7065 |
| 11:56 ET | 1216 | 5.67 |
| 11:58 ET | 800 | 5.69 |
| 12:00 ET | 808 | 5.69 |
| 12:02 ET | 106 | 5.69 |
| 12:05 ET | 300 | 5.7 |
| 12:07 ET | 400 | 5.7 |
| 12:09 ET | 1727 | 5.7 |
| 12:12 ET | 992 | 5.69 |
| 12:14 ET | 1049 | 5.67 |
| 12:16 ET | 473 | 5.68 |
| 12:20 ET | 100 | 5.69 |
| 12:21 ET | 200 | 5.68 |
| 12:23 ET | 500 | 5.68 |
| 12:25 ET | 100 | 5.66 |
| 12:27 ET | 200 | 5.67 |
| 12:32 ET | 313 | 5.6761 |
| 12:34 ET | 500 | 5.67 |
| 12:36 ET | 400 | 5.66 |
| 12:38 ET | 300 | 5.65 |
| 12:39 ET | 100 | 5.64 |
| 12:41 ET | 500 | 5.65 |
| 12:48 ET | 100 | 5.665 |
| 12:50 ET | 762 | 5.65 |
| 12:52 ET | 1984 | 5.65 |
| 12:54 ET | 2291 | 5.6444 |
| 12:57 ET | 900 | 5.64 |
| 01:01 ET | 3265 | 5.66 |
| 01:03 ET | 1100 | 5.64 |
| 01:06 ET | 200 | 5.63 |
| 01:08 ET | 100 | 5.63 |
| 01:10 ET | 100 | 5.63 |
| 01:12 ET | 300 | 5.625 |
| 01:14 ET | 2462 | 5.62 |
| 01:15 ET | 100 | 5.605 |
| 01:19 ET | 850 | 5.6 |
| 01:21 ET | 500 | 5.59 |
| 01:24 ET | 1697 | 5.595 |
| 01:26 ET | 400 | 5.61 |
| 01:30 ET | 5800 | 5.64 |
| 01:32 ET | 6590 | 5.62 |
| 01:33 ET | 3000 | 5.61 |
| 01:35 ET | 300 | 5.57 |
| 01:37 ET | 200 | 5.56 |
| 01:39 ET | 800 | 5.57 |
| 01:42 ET | 500 | 5.6 |
| 01:44 ET | 300 | 5.595 |
| 01:46 ET | 1100 | 5.62 |
| 01:48 ET | 1173 | 5.65 |
| 01:50 ET | 14359 | 5.6 |
| 01:55 ET | 1000 | 5.61 |
| 01:57 ET | 2500 | 5.62 |
| 02:00 ET | 300 | 5.62 |
| 02:02 ET | 1700 | 5.61 |
| 02:04 ET | 1849 | 5.61 |
| 02:06 ET | 3760 | 5.6 |
| 02:11 ET | 1600 | 5.61 |
| 02:13 ET | 100 | 5.61 |
| 02:15 ET | 100 | 5.61 |
| 02:18 ET | 200 | 5.61 |
| 02:20 ET | 743 | 5.59 |
| 02:22 ET | 200 | 5.58 |
| 02:24 ET | 1145 | 5.57 |
| 02:26 ET | 359 | 5.59 |
| 02:27 ET | 1045 | 5.595 |
| 02:31 ET | 200 | 5.595 |
| 02:33 ET | 100 | 5.595 |
| 02:36 ET | 100 | 5.595 |
| 02:38 ET | 100 | 5.595 |
| 02:40 ET | 200 | 5.595 |
| 02:42 ET | 333 | 5.59 |
| 02:44 ET | 200 | 5.59 |
| 02:45 ET | 270 | 5.595 |
| 02:47 ET | 400 | 5.59 |
| 02:51 ET | 700 | 5.59 |
| 02:54 ET | 100 | 5.59 |
| 02:56 ET | 400 | 5.585 |
| 02:58 ET | 1124 | 5.5963 |
| 03:00 ET | 326 | 5.59 |
| 03:02 ET | 820 | 5.58 |
| 03:03 ET | 100 | 5.58 |
| 03:05 ET | 1492 | 5.55 |
| 03:07 ET | 1040 | 5.57 |
| 03:09 ET | 500 | 5.59 |
| 03:12 ET | 2800 | 5.6 |
| 03:14 ET | 100 | 5.6 |
| 03:16 ET | 1002 | 5.6 |
| 03:18 ET | 100 | 5.6 |
| 03:20 ET | 1914 | 5.6 |
| 03:21 ET | 300 | 5.605 |
| 03:23 ET | 1400 | 5.62 |
| 03:25 ET | 5723 | 5.64 |
| 03:27 ET | 600 | 5.65 |
| 03:30 ET | 300 | 5.635 |
| 03:32 ET | 4321 | 5.6 |
| 03:34 ET | 400 | 5.6 |
| 03:36 ET | 300 | 5.61 |
| 03:38 ET | 745 | 5.62 |
| 03:39 ET | 100 | 5.625 |
| 03:41 ET | 1482 | 5.64 |
| 03:43 ET | 2187 | 5.64 |
| 03:45 ET | 1500 | 5.655 |
| 03:48 ET | 1471 | 5.65 |
| 03:50 ET | 2300 | 5.64 |
| 03:52 ET | 6570 | 5.66 |
| 03:54 ET | 2282 | 5.65 |
| 03:56 ET | 3500 | 5.645 |
| 03:57 ET | 4802 | 5.645 |
| 03:59 ET | 95270 | 5.61 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Prime Medicine Inc | 678.2M | -2.6x | --- |
Mind Medicine (MindMed) Inc | 677.0M | -3.2x | --- |
ProKidney Corp | 679.5M | -4.3x | --- |
Celcuity Inc | 672.2M | -6.7x | --- |
Mineralys Therapeutics Inc | 668.8M | -6.2x | --- |
ACELYRIN Inc | 666.5M | -2.7x | --- |
Company Information
Prime Medicine, Inc. is a biotechnology company engaged in creating and delivering the gene editing therapies to patients. It deploys its Prime Editing platform, a gene editing technology, to develop a new class of differentiated, one-time genetic therapies. It is engaged in developing Prime Editors as a new class of therapeutics with transformative potential to expand the application of curative precision genetic medicines. It has built a diversified portfolio of investigational therapeutic programs organized around core areas of focus, namely hematology and immunology, liver, lung, ocular and neuromuscular. The programs within its other areas of focus are on earlier stages of preclinical development and include Liver programs, such as Wilson's disease and glycogen storage disease 1b; Lung program, such as Cystic fibrosis; Ocular program, such as Retinitis pigmentosa caused by Rhodopsin mutations, and Neuromuscular programs, including Friedreich's ataxia and myotonic dystrophy type 1.
Contact Information
- Headquarters
- 60 First St.CAMBRIDGE, MA, United States 02141
- Phone
- 617-465-0013
- Fax
- 302-655-5049
Executives
- President, Chief Executive Officer, Director
- Keith Gottesdiener
- Co-Founder, Head of Prime Editing Platform
- Andrew Anzalone
- Chief Financial Officer
- Allan Reine
- Senior Vice President - Strategy and Corporate Operations
- Meredith Goldwasser
- Chief Technical Officer
- Ann Lee
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $678.2M |
|---|---|
Revenue (TTM) | $591.0K |
Shares Outstanding | 120.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-2.17 |
Book Value | $1.37 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 1,147.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -36,057.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
